Furthermore, an increased number of Treg can suppress immune response to tumor cells by inhibiting proliferation, activation, degranulation, and production of perforin and granzymes by CD8 + T cells (Chen et al., 2003), leading to poor disease prognosis (Gao et al., 2007). The gene discussed is PRF1; the disease is neoplasm.